Recombinant Human Insulin-like growth factor II (IGF2) (Active)

Code CSB-AP003891HU
Size $174
Order now
  • (Tris-Glycine gel) Discontinuous SDS-PAGE (reduced) with 5% enrichment gel and 15% separation gel.
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Greater than 95% as determined by SDS-PAGE.
Less than 1.0 EU/μg as determined by LAL method.
The ED50 as determined in a serum-free cell proliferation assay using MCF?7 human breast cancer cells is less than 20 ng/ml.
Target Names
Uniprot No.
Research Area
Signal Transduction
Alternative Names
C11orf43; IGF 2; IGF II; IGF-II; IGF2; IGF2_HUMAN; IGFII; INSIGF; insulin like growth factor 2 (somatomedin A) ; Insulin like Growth Factor 2; Insulin like growth factor II; Insulin like growth factor II precursor; Insulin like growth factor type 2; pp9974; Preptin; putative insulin like growth factor II associated protein; Somatomedin A; Somatomedin-A
Homo sapiens (Human)
Expression Region
Complete Sequence
Mol. Weight
8.91 kDa
Protein Length
Full Length of Mature Protein
Tag Info
Lyophilized powder
Lyophilized from a 0.2 μm filtered 20mM Glycine-HCl, 4% Sucrose, 4% Mannitol, 0.02% Tween 80 (w/v), pH3.0.
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final concentration of glycerol is 50%. Customers could use it as reference.
Troubleshooting and FAQs
Storage Condition
Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.
Shelf Life
The shelf life is related to many factors, storage state, buffer ingredients, storage temperature and the stability of the protein itself.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
Lead Time
Basically, we can dispatch the products out in 5-10 working days after receiving your orders. Delivery time may differ from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Datasheet & COA
Please contact us to get it.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

The insulin-like growth factors possess growth-promoting activity. Major fetal growth hormone in mammals. Plays a key role in regulating fetoplacental development. IGF2 is influenced by placental lactogen. Also involved in tissue differentiation. In adults, involved in glucose metabolism in adipose tissue, skeletal muscle and liver (Probable). Acts as a ligand for integrin which is required for IGF2 signaling. Positively regulates myogenic transcription factor MYOD1 function by facilitating the recruitment of transcriptional coactivators, thereby controlling muscle terminal differentiation. Inhibits myoblast differentiation and modulates metabolism via increasing the mitochondrial respiration rate.; Preptin undergoes glucose-mediated co-secretion with insulin, and acts as physiological amplifier of glucose-mediated insulin secretion. Exhibits osteogenic properties by increasing osteoblast mitogenic activity through phosphoactivation of MAPK1 and MAPK3.
Gene References into Functions
  1. serum preptin levels in women decrease after menopause and have a positive correlation with estradiol, femoral and total hip bone mineral density. PMID: 29134283
  2. Analysis of patient serum samples showed that concurrent elevation of insulin like growth factor 2 (IGF2) and vascular endothelial growth factor (VEGF) levels may serve as a prognostic biomarker for oesophageal cancer. PMID: 28186102
  3. Our results revealed that IGF-II promotes cell proliferation and EMT in HCC cells. PMID: 29970663
  4. Serum preptin levels were significantly higher in women with polycystic ovary syndrome compared with controls. PMID: 29374985
  5. infants with intrauterine growth restriction had higher serum levels of IGF2 if they had the A/G genotype at the ApaI restriction fragment length polymorphism and higher values of IGF2R if they had the A/A genotype PMID: 28460554
  6. Upregulation of IGF-II expression is associated with ovarian cancer. PMID: 28829218
  7. Data suggest that high IGF2 DMR methylation status would be a phenomenon that is observed with the progression of gastric cancer (GC) toward more aggressive features, supporting their potential utility as a biomarker in GC patients. PMID: 28871451
  8. Data suggest that expression of CDKN1C and IGF2 is significantly up-regulated in placenta after assisted reproductive technology; DNA methylation was significantly down-regulated in DMR of CDKN1C and up-regulated in DMR of IGF2. (CDKN1C = cyclin-dependent kinase inhibitor-1C; IGF2 = insulin like growth factor 2; DMR = differential methylation regions) PMID: 29277274
  9. The expression of miR-3941 was significantly down-regulated in acute pneumonia; IGF2 was confirmed as a direct target gene of miR-3941. PMID: 29328418
  10. Our data reveal that vigilin is essential for maintenance of imprinting of IGF2 gene via functional interaction between KH1-7 domains of vigilin and zinc-finger domains of CTCF. PMID: 29157910
  11. Low IGF-II serum levels were associated with Pancreatic Cancer. PMID: 28681154
  12. Rapamycin-independent IGF2 expression in Tsc2-null mouse embryo fibroblasts and human lymphangioleiomyomatosis cells. PMID: 29758070
  13. IGF2 rs680 polymorphism may have a role in endurance among Israeli athletes PMID: 29107196
  14. low methylation of the Igf2 gene promoter region may promote the expression of Igf2 and miR4835p; this, in turn, induces the degradation of miR4835p target genes, and leads to the upregulation of oncogenes and the downregulation of tumor suppressors, which promotes the development of ESCC. PMID: 29207103
  15. Results found IGF2 as a direct target gene of miR615 and restoring its expression reverses the inhibitory effects of miR615 in human esophageal squamous cell carcinoma cell motility. PMID: 29115555
  16. A common indel variant in the 3'UTR of the IGF2 gene was associated with the risk of impaired renal function in an elderly population. PMID: 29889555
  17. High molecular weight IGF-2 was associated with hypoglycemia in Recurrent Renal Cell Carcinoma. PMID: 24711554
  18. Impairment of IGF2 gene expression in prostate cancer is triggered by epigenetic dysregulation of IGF2-DMR0 and its interaction with KLF4 PMID: 29017567
  19. HMGA1P7 mRNA sustains the H19 and Igf2 overexpression by acting as miRNA decoy. PMID: 27874091
  20. Data suggest that blocking insulin-like growth factor 2 (IGF2) is a potential therapeutic mechanism for hepatocellular carcinoma (HCC). PMID: 29413895
  21. IGF2 expression varies among mesenchymal stem cells derived from amniotic fluid, amnion, endometrium, and Wharton's jelly during culture period. PMID: 28629288
  22. Results showed that IGF-2 was persistently expressed in oculomotor neurons in health and amyotrophic lateral sclerosis (ALS) and thus could play a role in oculomotor resistance in this disease. PMID: 27180807
  23. Studies indicate that miR-663b is epigenetically repressed by long non-coding RNA HOTAIR and exerts its tumor-suppressive function via targeting insulin-like growth factor 2 (IGF2) in pancreatic cancer. PMID: 27895308
  24. IGF-II-mediated loss of E-cadherin is central in developing hepatomegaly in mice and abnormal cell growth in the hepatoma cell line PMID: 27486970
  25. Aberrant IGF2 imprinting may be an intrinsic epigenetic control mechanism that enhances stemness, self-renewal and chemo/radiotherapy resistance in cancer stem cells. PMID: 27275535
  26. DNMT1-mediated transcriptional upregulation of IGF2 is a novel mechanism of resistance to HDIs, highlighting the role of epigenetic deregulation of IGF2 in HDI resistance and the potential value of the H19/IGF2 ICR hypermethylation and DNMT1 expression as predictive biomarkers in HDI-based anticancer therapies. PMID: 27582487
  27. Human H19/Igf2 imprinting control regions can functionally replace mouse H19/Igf2 imprinting control regions on the maternal allele. PMID: 27621468
  28. IGF2 may exert its oncofunction, at least partly, through its parasitic miR-483 which suppressed DLC-1 in colorectal cancer cells. PMID: 27366946
  29. We report here the first deletions of ICR1 associated with hypomethylation of the IGF2/H19 domain leading to SRS. PMID: 27701793
  30. Methylation patterns of IGF2 regulatory regions can discriminate adrenocortical carcinomas from adrenocortical adenomas with high diagnostic accuracy. PMID: 27535174
  31. IGF-II siRNA inactivates the FAK/PI3K/Akt signaling pathway, and further reduces cell proliferation, N-ras and C-myc levels in SMMC-7721 cells. PMID: 27768959
  32. Study shows impact of folic acid intake during pregnancy on genomic imprinting of IGF2/H19 and 1-carbon metabolism PMID: 28778973
  33. produced by pericentral hepatocytes to promote hepatocyte proliferation and repair tissue damage in the setting of chronic liver injury PMID: 28653763
  34. These findings suggest that reducing IGF2 isoform 2 expression in relevant tissues has potential as a new therapeutic strategy for type 2 diabetes, even beyond the Latin American population, with no major adverse effects on health or reproduction. PMID: 28838971
  35. this is the first report of IGF2/H19 domain triplication associated with BWS or SRS and the second report of a maternal amplification of this region in a patient with clinical features of SRS. This study further supports the hypotheses that the amplification of the H19/IGF2 region on the maternal chromosome can lead to an SRS phenotype. PMID: 27612309
  36. stroma-induced IGF2 promotes colon cancer progression in a paracrine and autocrine manner and propose IGF2 as potential target for tumor stroma cotargeting strategies. PMID: 28534511
  37. We identified vascular INSR expression as a potential biomarker for progression in bladder cancer. The data suggest that IGF-2/INSR mediated paracrine crosstalk between bladder cancer cells and endothelial cells is functionally involved in tumour angiogenesis and may thus represent a new therapeutic target. PMID: 28295307
  38. Methylation of IGF2AS is altered 20 years after preterm birth at VLBW. Altered methylation may be a mechanism of later increased disease risk but more data are needed to indicate causality PMID: 23840686
  39. Prenatal 'unhealthy diet' was positively associated with IGF2 methylation at birth, and with ADHD and conduct disorder. PMID: 27535767
  40. High IGF2 expression is associated with breast cancer. PMID: 27546618
  41. IGF2 and insulin receptor A are important for uterine leiomyoma stem cell proliferation and may represent paracrine signaling between leiomyoma cell types. PMID: 28324020
  42. IGF2 overexpression is associated with cancer. PMID: 27869826
  43. Long non-coding RNA 91H is overexpressed in breast cancer and 91H-induced epigenetic modifications on H19/IGF2 locus suggest that 91H may play essential role in breast cancer development. PMID: 27780718
  44. our results suggest that IGF2 via AKT1 contributes to non-canonical wnt signaling. PMID: 26984550
  45. Elevated insulin-like growth factor 2 expression is associated with Beckwith-Wiedemann syndrome. PMID: 27650505
  46. Here we present IGF2, which is re-expressed through epigenetic mechanisms, as the first actionable validated epi-driver in hepatocellular carcinoma. PMID: 27614046
  47. results demonstrate that the H19-Igf2 axis is negatively regulated by CTCF-PHB1 cooperation and that H19 is involved in modulating the growth-suppressive effect of PHB1 in the liver. PMID: 27687727
  48. Compared with obstructive azoospermia (OA) as normal control, our results suggest that miR-210 was significantly up-regulated in testis of patients with non-obstructive azoospermia (P<0.05), and IGF2 was down-regulated, but without a significant difference. PMID: 27535712
  49. The identification of the INS-IGF2 read-through transcript specifically in tumor tissue but not in normal pancreatic tissue suggests that high expression of INS-IGF2 could be neoplasiaspecific PMID: 27667266
  50. DNA methylation of imprinted loci of IGF2 is not affected in Parkinson's disease patients. PMID: 28081695

Show More

Hide All

Involvement in disease
Silver-Russell syndrome (SRS); Growth restriction, severe, with distinctive facies (GRDF)
Subcellular Location
Protein Families
Insulin family
Tissue Specificity
Expressed in heart, placenta, lung, liver, muscle, kidney, tongue, limb, eye and pancreas.
Database Links

HGNC: 5466

OMIM: 147470

KEGG: hsa:3481

STRING: 9606.ENSP00000391826

UniGene: Hs.272259

CUSABIO guaranteed quality
icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details


II. Contact details


III. Ship To


IV. Bill To